The lungs are one of the last organs in the body to develop as a baby grows. They're also one of the most important.
Stratification of monitoring protocols based on the risk profile of the patient can help us in the future to better care for people with Cystic Fibro…
The proposed study intends to explore parental experiences, including coping, related to their child's involvement in the early surveillance program.
This study aimed to investigate the information needs, priorities, and information-seeking behaviours of parents of infants newly diagnosed with CF.
The aim of this study was to determine whether assessment of early CT scan-detected bronchiectasis in young children with cystic fibrosis (CF) depend…
Clinical trials for the treatment of cystic fibrosis (CF) lung disease are important to test and optimise new therapeutic interventions.
To examine the distribution of early structural lung changes in clinically stable infants and young children with cystic fibrosis using chest compute…
Cystic fibrosis (CF) lung disease commences early in the disease progression and is the most common cause of mortality.
Researchers at Perth's Telethon Institute are one step closer to preventing serious lung disease which is the main cause of suffering in cystic fibro…
We sought to determine risk factors for the onset of bronchiectasis, using data collected by the Australian Respiratory Early Surveillance Team for C…